When did INTERCEPT PHARMACEUTICALS IN (ICPT) report earnings last quarter?
INTERCEPT PHARMACEUTICALS IN (ICPT) last reported earnings on 11/6/2023.
INTERCEPT PHARMACEUTICALS IN (ICPT) Earnings History & Surprises
NASDAQ:ICPT • US45845P1084
Current stock price
19 USD
+0.04 (+0.21%)
At close:
19 USD
0 (0%)
After Hours:
ICPT Earnings overview
Past quarterly earnings results for INTERCEPT PHARMACEUTICALS IN (ICPT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Feb 29, 2024
- Period
- Q4 / 2023
- EPS Estimate
- $0.03
- Revenue Estimate
- 92.785M
Last Reported
Most Recent- Release Date
- Nov 6, 2023
- Period
- Q3 / 2023
- EPS Reported
- $0.08
- EPS Surprise
- 117.78%
- Revenue Surprise
- -1.65%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | 0.08 | -0.45 | 117.78% | -98.97% | 88.789M | 90.28M | -1.65% | 14.44% |
| Q2 2023 | -0.14 | -0.52 | 73.02% | 79.41% | 83.718M | 81.158M | 3.15% | 16.67% |
| Q1 2023 | -0.77 | -0.66 | -16.57% | -32.76% | 67.958M | 73.664M | -7.75% | 14.90% |
| Q4 2022 | -0.50 | -0.16 | -203.66% | 59.35% | 77.219M | 79.638M | -3.04% | 12.51% |
| Q3 2022 | 7.80 | 4.70 | 66.01% | 1,338.10% | 77.588M | 75.549M | 2.70% | 16.43% |
| Q2 2022 | -0.68 | -0.50 | -36.76% | -106.06% | 71.757M | 97.639M | -26.51% | 5.25% |
| Q1 2022 | -0.58 | -0.92 | 36.95% | 52.46% | 59.146M | 91.5M | -35.36% | -27.57% |
| Q4 2021 | -1.23 | -1.12 | -9.94% | 22.15% | 68.633M | 94.233M | -27.17% | -17.58% |
| Q3 2021 | -0.63 | -1.11 | 43.37% | 60.87% | 66.64M | 84.676M | -21.30% | -16.20% |
| Q2 2021 | -0.33 | -1.24 | 73.43% | 82.81% | 68.178M | 84.338M | -19.16% | -11.74% |
| Q1 2021 | -1.22 | -1.47 | 17.08% | 57.34% | 81.66M | 82.839M | -1.42% | 12.40% |
| Q4 2020 | -1.58 | -1.50 | -5.09% | - | 83.27M | 86.706M | -3.96% | - |
| Q3 2020 | -1.61 | -1.97 | 18.30% | - | 79.52M | 80.202M | -0.85% | - |
| Q2 2020 | -1.92 | -2.97 | 35.44% | - | 77.25M | 73.592M | 4.97% | - |
| Q1 2020 | -2.86 | -2.96 | 3.38% | - | 72.65M | 71.055M | 2.24% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-7.36%
Max EPS beat (4)
117.78%
Min EPS beat (4)
-203.66%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-2.32%
Max Revenue beat (4)
3.15%
Min Revenue beat (4)
-7.75%
Analysis
In the last 4 quarters, ICPT has beaten EPS estimates in 2 out of 4 releases
ICPT has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, ICPT reported -7.4% below the EPS estimates on average.
In the last 4 quarters, ICPT reported -2.3% below the revenue estimates on average.
Related analysis
INTERCEPT PHARMACEUTICALS IN / ICPT Earnings FAQ
Did INTERCEPT PHARMACEUTICALS IN (ICPT) beat earnings estimates last quarter?
INTERCEPT PHARMACEUTICALS IN (ICPT) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often INTERCEPT PHARMACEUTICALS IN beats earnings estimates?
In the last 4 quarters, INTERCEPT PHARMACEUTICALS IN (ICPT) has beaten EPS estimates in 2 out of 4 releases.